Dramina 50mg tablets are used to relieve motion sickness symptoms. Pack of 10 tablets.
Composition: Each tablet contains: Active ingredient: Dimenhydrinate 50 mg. Excipients: Ludipress (lactose monohydrate, povidone, crospovidone), microcrystalline cellulose, magnesium stearate.
Indications: Prevention and treatment of motion sickness (sea, car, and air sickness); prevention and treatment of symptoms associated with vestibular and labyrinthine disorders (dizziness, nausea, vomiting), except symptoms caused by anticancer therapy; Ménière's disease.
Contraindications: Hypersensitivity to the components of the medicine, epilepsy, acute exudative and vesicular dermatoses, children under 3 years of age, pregnancy, and breastfeeding.
Special Warnings and Precautions: The medicine should be used with caution in patients with seizure disorders, angle-closure glaucoma, benign prostatic hyperplasia, bronchial asthma, cardiovascular diseases, hyperthyroidism, stenosing peptic ulcer, pyloroduodenal obstruction, and bladder neck obstruction.
Pregnancy and Lactation: Contraindicated during the first trimester of pregnancy. During the second and third trimesters, the medicine may be used with particular caution if the expected benefit outweighs the potential risk to the fetus. Breastfeeding should be discontinued during treatment.
Dosage and Administration:
The medicine is taken orally, preferably after meals, with an adequate amount of water.
Motion sickness (sea, car, and air sickness):
Prevention and treatment of vestibular and labyrinthine disorders:
Ménière's disease:
The maximum daily dose for adults should not exceed 7 tablets.
For the prevention of motion sickness, it is recommended to take the prescribed dose 30 minutes before travel.
The duration of treatment and the need for repeated courses should be determined by a physician.
Effects on Ability to Drive and Operate Machinery: Due to possible side effects, caution is advised when driving vehicles or operating machinery requiring increased attention and rapid psychomotor reactions.
Storage Conditions: Store at a temperature not exceeding 25°C, out of the reach of children.
Dispensing Status: Pharmaceutical Product Group III. Available without a prescription.
